Latest news
Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 00:33:27 GMTFDA Clears a Second Colorectal Cancer Blood Test, and the Trade-Off Is in What It Misses - Medical DailyMedical Daily · Wed, 05 Aug 2026 15:00:07 GMTCombination Regimen Prolongs PFS in dMMR-MSI-H Metastatic Colorectal Cancer - The ASCO PostThe ASCO Post · Wed, 05 Aug 2026 14:56:39 GMTVerastem Oncology Doses First Patient in TARGET-D 203 Phase 2 Registration-Directed Trial of VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor for KRAS G12D-Mutated Metastatic Colorectal Cancer - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMT